Julie Rosenthal, MD, MS, discusses the future direction of research into treating age-related macular degeneration.
Patients with neovascular age‑related macular degeneration (AMD) whose retinal fluid cleared within 12 weeks of starting faricimab were more likely to have longer intervals between injections later in ...
Injection-free subgroup results demonstrated that a single intravitreal dose of 4D-150 without any supplemental anti-VEGF injections resulted in stable mean visual acuity that was equal to or higher ...
Oraya Therapeutics Inc. announced today that leading ophthalmologists from three European countries presented patient results following one year after a single treatment with Oraya Therapy for wet age ...
Newmedica Worcester highlights AMD Awareness Month, urging early detection of age-related macular degeneration—the UK’s leading cause of ...
Newmedica Oxfordshire is highlighting the signs of age-related macular degeneration (AMD) during AMD Awareness Month and is calling for the NHS to publish clearer data on its waiting lists for AMD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results